Unichem Laboratories Limited (NSE:UNICHEMLAB)
India · Delayed Price · Currency is INR 503.05
-3.95 (-0.78%)
Aug 29, 2025, 3:29 PM IST
Unichem Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 21,542 | 21,110 | 17,851 | 13,430 | 12,698 | 12,351 | Upgrade | |
Revenue Growth (YoY) | 24.66% | 18.25% | 32.92% | 5.76% | 2.81% | 11.91% | Upgrade |
Cost of Revenue | 9,742 | 9,219 | 7,949 | 6,064 | 4,686 | 4,260 | Upgrade |
Gross Profit | 11,800 | 11,891 | 9,903 | 7,366 | 8,013 | 8,091 | Upgrade |
Selling, General & Admin | 4,261 | 4,208 | 4,263 | 3,690 | 3,468 | 3,113 | Upgrade |
Other Operating Expenses | 5,068 | 5,034 | 4,771 | 4,098 | 3,742 | 4,062 | Upgrade |
Operating Expenses | 10,571 | 10,488 | 10,265 | 8,922 | 8,122 | 8,018 | Upgrade |
Operating Income | 1,229 | 1,403 | -362.8 | -1,556 | -109.01 | 72.76 | Upgrade |
Interest Expense | -232.1 | -207 | -221.5 | -162.52 | -50.21 | -44 | Upgrade |
Interest & Investment Income | 28.5 | 28.5 | 6.7 | 5.22 | 164.91 | 229.43 | Upgrade |
Earnings From Equity Investments | - | - | - | - | -10.61 | -3.43 | Upgrade |
Currency Exchange Gain (Loss) | 215.6 | 215.6 | 224 | 273.16 | 273.82 | 105.39 | Upgrade |
Other Non Operating Income (Expenses) | 19.5 | 3.7 | -0.9 | -41.33 | -29.37 | 43.45 | Upgrade |
EBT Excluding Unusual Items | 1,261 | 1,444 | -354.5 | -1,481 | 239.53 | 403.6 | Upgrade |
Gain (Loss) on Sale of Investments | 92.6 | 92.6 | 64.7 | 90.49 | -17.49 | 116.42 | Upgrade |
Gain (Loss) on Sale of Assets | 24.3 | 9.5 | 16.3 | 12.83 | -2.34 | -5.23 | Upgrade |
Other Unusual Items | - | - | -576.1 | -385.66 | - | - | Upgrade |
Pretax Income | 1,378 | 1,546 | -849.6 | -1,764 | 219.69 | 514.79 | Upgrade |
Income Tax Expense | 127.8 | 170.7 | 88 | 258.65 | -110.93 | 171.55 | Upgrade |
Earnings From Continuing Operations | 1,250 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 | Upgrade |
Net Income | 1,250 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 | Upgrade |
Net Income to Common | 1,250 | 1,375 | -937.6 | -2,022 | 330.62 | 343.25 | Upgrade |
Net Income Growth | - | - | - | - | -3.68% | - | Upgrade |
Shares Outstanding (Basic) | 70 | 70 | 70 | 70 | 70 | 70 | Upgrade |
Shares Outstanding (Diluted) | 70 | 71 | 70 | 70 | 71 | 70 | Upgrade |
Shares Change (YoY) | 1.21% | 0.31% | - | -0.25% | 0.25% | 0.01% | Upgrade |
EPS (Basic) | 17.82 | 19.53 | -13.32 | -28.72 | 4.70 | 4.88 | Upgrade |
EPS (Diluted) | 17.76 | 19.47 | -13.32 | -28.72 | 4.68 | 4.88 | Upgrade |
EPS Growth | - | - | - | - | -4.01% | - | Upgrade |
Free Cash Flow | - | -1,444 | -85.5 | -1,294 | -3,866 | -2,548 | Upgrade |
Free Cash Flow Per Share | - | -20.44 | -1.21 | -18.38 | -54.78 | -36.20 | Upgrade |
Dividend Per Share | - | - | - | - | 4.000 | 4.000 | Upgrade |
Gross Margin | 54.78% | 56.33% | 55.47% | 54.85% | 63.10% | 65.51% | Upgrade |
Operating Margin | 5.71% | 6.65% | -2.03% | -11.58% | -0.86% | 0.59% | Upgrade |
Profit Margin | 5.80% | 6.51% | -5.25% | -15.06% | 2.60% | 2.78% | Upgrade |
Free Cash Flow Margin | - | -6.84% | -0.48% | -9.63% | -30.45% | -20.63% | Upgrade |
EBITDA | 2,403 | 2,577 | 810.7 | -480.19 | 747.05 | 838.59 | Upgrade |
EBITDA Margin | 11.15% | 12.21% | 4.54% | -3.57% | 5.88% | 6.79% | Upgrade |
D&A For EBITDA | 1,174 | 1,174 | 1,174 | 1,076 | 856.06 | 765.83 | Upgrade |
EBIT | 1,229 | 1,403 | -362.8 | -1,556 | -109.01 | 72.76 | Upgrade |
EBIT Margin | 5.71% | 6.65% | -2.03% | -11.58% | -0.86% | 0.59% | Upgrade |
Effective Tax Rate | 9.28% | 11.04% | - | - | - | 33.32% | Upgrade |
Revenue as Reported | 21,926 | 21,463 | 18,167 | 13,815 | 13,173 | 12,853 | Upgrade |
Advertising Expenses | - | 168.2 | 215.2 | 117.46 | 144.12 | 26.81 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.